Badr Alzahrani

786 total citations
50 papers, 440 citations indexed

About

Badr Alzahrani is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Badr Alzahrani has authored 50 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Badr Alzahrani's work include Liver Disease Diagnosis and Treatment (8 papers), Nanoparticles: synthesis and applications (6 papers) and MicroRNA in disease regulation (4 papers). Badr Alzahrani is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Nanoparticles: synthesis and applications (6 papers) and MicroRNA in disease regulation (4 papers). Badr Alzahrani collaborates with scholars based in Saudi Arabia, Malaysia and India. Badr Alzahrani's co-authors include Lionel Hebbard, Tristan J. Iseli, Pooi Ling Mok, Suresh Kumar, Abdullah Alsrhani, Abozer Y. Elderdery, Hasan Ejaz, Sonia Younas, Liang Qiao and Jacob George and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Badr Alzahrani

45 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Badr Alzahrani Saudi Arabia 11 130 113 67 55 46 50 440
Aftab Ullah China 14 230 1.8× 67 0.6× 53 0.8× 57 1.0× 34 0.7× 37 639
Nahed Mohamed Egypt 11 97 0.7× 37 0.3× 44 0.7× 52 0.9× 12 0.3× 26 387
Anna Ballard United States 10 154 1.2× 67 0.6× 67 1.0× 15 0.3× 42 0.9× 14 397
Xinrui Zhang China 17 262 2.0× 67 0.6× 29 0.4× 20 0.4× 31 0.7× 61 761
Jin Chul Kim South Korea 14 227 1.7× 136 1.2× 47 0.7× 18 0.3× 17 0.4× 24 592
Azza Elkady Egypt 10 159 1.2× 42 0.4× 127 1.9× 53 1.0× 10 0.2× 17 415
Haiting Xu China 15 316 2.4× 54 0.5× 44 0.7× 43 0.8× 12 0.3× 33 791
Zhen‐shu Zhang China 11 201 1.5× 71 0.6× 25 0.4× 9 0.2× 54 1.2× 35 517
Linlin Wei China 14 207 1.6× 198 1.8× 16 0.2× 24 0.4× 131 2.8× 49 693

Countries citing papers authored by Badr Alzahrani

Since Specialization
Citations

This map shows the geographic impact of Badr Alzahrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Badr Alzahrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Badr Alzahrani more than expected).

Fields of papers citing papers by Badr Alzahrani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Badr Alzahrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Badr Alzahrani. The network helps show where Badr Alzahrani may publish in the future.

Co-authorship network of co-authors of Badr Alzahrani

This figure shows the co-authorship network connecting the top 25 collaborators of Badr Alzahrani. A scholar is included among the top collaborators of Badr Alzahrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Badr Alzahrani. Badr Alzahrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ikram, Aqsa, et al.. (2023). An In Silico Deep Learning Approach to Multi-Epitope Vaccine Design: A Hepatitis E Virus Case Study. Vaccines. 11(3). 710–710. 10 indexed citations
4.
Alsrhani, Abdullah, Abozer Y. Elderdery, Badr Alzahrani, et al.. (2023). Therapeutic Potential of Albumin Nanoparticles Encapsulated Visnagin in MDA-MB-468 Triple-Negative Breast Cancer Cells. Molecules. 28(7). 3228–3228. 5 indexed citations
5.
Alzahrani, Badr, Abozer Y. Elderdery, Nasser A. N. Alzerwi, et al.. (2023). Pluronic-F-127-Passivated SnO2 Nanoparticles Derived by Using Polygonum cuspidatum Root Extract: Synthesis, Characterization, and Anticancer Properties. Plants. 12(9). 1760–1760. 8 indexed citations
6.
Jamal, Syed Babar, et al.. (2023). Development of a tetravalent subunit vaccine against dengue virus through a vaccinomics approach. Frontiers in Immunology. 14. 1273838–1273838. 9 indexed citations
7.
Alzahrani, Badr, Abozer Y. Elderdery, Abdullah Alsrhani, et al.. (2023). Effects of Albumin–Chlorogenic Acid Nanoparticles on Apoptosis and PI3K/Akt/mTOR Pathway Inhibitory Activity in MDA-MB-435s Cells. Nanomaterials. 13(9). 1438–1438. 6 indexed citations
8.
Althobiti, Maryam, Badr Alzahrani, Abozer Y. Elderdery, et al.. (2023). In vitro anti-cancer and antimicrobial effects of manganese oxide nanoparticles synthesized using the Glycyrrhiza uralensis leaf extract on breast cancer cell lines. Green Processing and Synthesis. 12(1). 4 indexed citations
9.
Jamal, Syed Babar, et al.. (2023). In-silico drug design for the novel Karachi-NF001 strain of brain-eating amoeba: Naegleria fowleri. Frontiers in Molecular Biosciences. 10. 1098217–1098217. 6 indexed citations
10.
Elderdery, Abozer Y., et al.. (2022). Synthesis and characterization of ZnO–TiO 2 –chitosan–escin metallic nanocomposites: Evaluation of their antimicrobial and anticancer activities. Green Processing and Synthesis. 11(1). 1026–1039. 5 indexed citations
11.
Alzahrani, Badr, et al.. (2022). IL-10 rs1800896 Polymorphism: A Risk Factor for Adult Acute Lymphoblastic Leukemia. Pharmacogenomics and Personalized Medicine. Volume 15. 809–815. 4 indexed citations
12.
Alzahrani, Badr, et al.. (2022). Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injury. Journal of Pathology and Translational Medicine. 56(2). 81–91. 9 indexed citations
13.
Elderdery, Abozer Y., et al.. (2022). Molecular Analysis of Xmn1-Polymorphic Site ´5 to Gγ of the β-Globin Gene Cluster in a Saudi Population of Jazan Region in Correlation with Hb F Expression. Evidence-based Complementary and Alternative Medicine. 2022. 1–6.
14.
Alzahrani, Badr, et al.. (2022). Increased Risk of Acute Lymphoblastic Leukemia in Adult Patients with GSTM1 Null Genetic Polymorphism. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Elderdery, Abozer Y., et al.. (2022). Synthesis of nickel cobalt-codoped tin oxide nanoparticles from Psidium guajava with anticancer properties. Arabian Journal of Chemistry. 16(2). 104481–104481. 7 indexed citations
16.
Ikram, Aqsa, Bisma Rauff, Badr Alzahrani, et al.. (2022). Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development. Scientific Reports. 12(1). 15648–15648. 4 indexed citations
17.
Ejaz, Hasan, Sonia Younas, Khalid Omer Abdalla Abosalif, et al.. (2021). Molecular analysis of blaSHV, blaTEM, and blaCTX-M in extended-spectrum β-lactamase producing Enterobacteriaceae recovered from fecal specimens of animals. PLoS ONE. 16(1). e0245126–e0245126. 55 indexed citations
18.
Jackson, Denise E., et al.. (2021). Combined GSTT1 Null, GSTM1 Null and XPD Lys/Lys Genetic Polymorphisms and Their Association with Increased Risk of Chronic Myeloid Leukemia. Pharmacogenomics and Personalized Medicine. Volume 14. 1661–1667. 5 indexed citations
19.
Alzahrani, Badr, et al.. (2021). Therapeutic Impact of ODN2088 to Block TLR9 Activity in Induced Liver Fibrosis Mice. Pakistan Journal of Biological Sciences. 24(1). 122–131. 1 indexed citations
20.
Alzahrani, Badr, et al.. (2020). Determination of Serum Adiponectin Levels in Type 2 Diabetes Patients of the Saudi Population in the Al-Jouf Region. 27(3). 257–262. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aftab Ullah Breakdown of academic impact, for papers by Nahed Mohamed Breakdown of academic impact, for papers by Anna Ballard Breakdown of academic impact, for papers by Xinrui Zhang Breakdown of academic impact, for papers by Jin Chul Kim Breakdown of academic impact, for papers by Azza Elkady Breakdown of academic impact, for papers by Haiting Xu Breakdown of academic impact, for papers by Zhen‐shu Zhang Breakdown of academic impact, for papers by Linlin Wei
Rankless by CCL
2026